[go: up one dir, main page]

AU8225391A - The use of inositolmonophosphate for the preparing of a medicament effective as a neuropeptide gamma-antagonist - Google Patents

The use of inositolmonophosphate for the preparing of a medicament effective as a neuropeptide gamma-antagonist

Info

Publication number
AU8225391A
AU8225391A AU82253/91A AU8225391A AU8225391A AU 8225391 A AU8225391 A AU 8225391A AU 82253/91 A AU82253/91 A AU 82253/91A AU 8225391 A AU8225391 A AU 8225391A AU 8225391 A AU8225391 A AU 8225391A
Authority
AU
Australia
Prior art keywords
inositolmonophosphate
antagonist
preparing
medicament effective
neuropeptide gamma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU82253/91A
Other languages
English (en)
Inventor
Lars Edvinsson
Bo Fallgren
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Perstorp AB
Original Assignee
Perstorp AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Perstorp AB filed Critical Perstorp AB
Publication of AU8225391A publication Critical patent/AU8225391A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU82253/91A 1990-07-04 1991-06-27 The use of inositolmonophosphate for the preparing of a medicament effective as a neuropeptide gamma-antagonist Abandoned AU8225391A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9002342 1990-07-04
SE9002342A SE467340B (sv) 1990-07-04 1990-07-04 Anvaendning av inositolmonofosfat foer framstaellning av ett laekemedel effektivt som en neuropeptid y-(npy-)antagonist

Publications (1)

Publication Number Publication Date
AU8225391A true AU8225391A (en) 1992-02-04

Family

ID=20379939

Family Applications (1)

Application Number Title Priority Date Filing Date
AU82253/91A Abandoned AU8225391A (en) 1990-07-04 1991-06-27 The use of inositolmonophosphate for the preparing of a medicament effective as a neuropeptide gamma-antagonist

Country Status (3)

Country Link
AU (1) AU8225391A (fr)
SE (1) SE467340B (fr)
WO (1) WO1992000744A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993012139A1 (fr) * 1991-12-19 1993-06-24 Garvan Institute Of Medical Research Nouvelle molecule inhibant la fonction biologique du neuropeptide tyrosine

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5550166A (en) * 1995-03-17 1996-08-27 Ostlund; Richard E. Pinitol and derivatives thereof for the treatment of metabolic disorders
JP4106711B2 (ja) * 1996-03-21 2008-06-25 萬有製薬株式会社 アミノピリジン誘導体
FR2754709B1 (fr) * 1996-10-23 1999-03-05 Sanofi Sa Composition cosmetique contenant un antagoniste des recepteurs du neuropeptide gamma et alpha 2 antagonistes susceptibles d'etre incorpores dans une telle composition
IL122077A0 (en) * 1997-10-30 1998-03-10 Univ Ben Gurion Epi-inositol compositions for the treatment of CNS disorders
AU5277000A (en) 1999-05-20 2000-12-12 Humanetics Corporation Stimulating transport of glucose into animal tissue by the administration of pinitol
KR20040051455A (ko) * 2002-12-12 2004-06-18 아미코젠주식회사 산화적 손상을 예방하기 위한 카이로이노시톨 또는피니톨의 용도 및 이들을 함유하는 당뇨합병증 예방용조성물
KR20040084168A (ko) * 2003-03-26 2004-10-06 아미코젠주식회사 피니톨 또는 카이로이노시톨을 포함하는 간 질환 예방 및치료용 조성물
EP1858519B1 (fr) * 2005-03-12 2013-02-20 Bitop Aktiengesellschaft Für Biotechnische Optimierung Ectoin et/u hydroxyectoin pour la prévention et le traitement des maladies inflammatoires chroniques intestinales
DE102008039231A1 (de) 2008-08-22 2010-02-25 Bitop Ag Verwendung von Glucosylglycerol

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01294631A (ja) * 1988-05-19 1989-11-28 Sanwa Kagaku Kenkyusho Co Ltd 糖尿性疾患治療予防剤及び飲食、し好物
US5211956A (en) * 1988-05-19 1993-05-18 Sanwa Kagaku Kenkyusho Co., Ltd. Pharmaceutical compositions containing phytic acid or its salts
US5041429A (en) * 1988-06-01 1991-08-20 Sanwa Kagaku Kenkyusho Co., Ltd. Cell activators, circulatory ameliorators and edible compositions
SE464059C (sv) * 1988-09-15 1997-06-02 Perstorp Ab Användning av inositoltrifosfat för framställning av läkemedel
JPH02289592A (ja) * 1989-04-28 1990-11-29 Sanwa Kagaku Kenkyusho Co Ltd 新規組成物及びその用途

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993012139A1 (fr) * 1991-12-19 1993-06-24 Garvan Institute Of Medical Research Nouvelle molecule inhibant la fonction biologique du neuropeptide tyrosine

Also Published As

Publication number Publication date
SE9002342D0 (sv) 1990-07-04
SE467340B (sv) 1992-07-06
WO1992000744A1 (fr) 1992-01-23

Similar Documents

Publication Publication Date Title
AU7122291A (en) 3-arylcarbonyl-1h-indoles useful as therapeutic agents
AU656157B2 (en) Pharmaceutical agents
AU3888793A (en) Novel medicament
AU5926794A (en) Medicament pack
AU6062590A (en) Pharmaceutically active compounds
IL104067A0 (en) Preparation of a pharmaceutical composition selectively lowering the blood-lipid level
AP9100283A0 (en) Pharmaceutical compounds
SG44638A1 (en) Novel alkylenediammonium diclavulante derivatives a process for the preparation thereof as well as the use thereof
AU9128891A (en) Single use syringe
AU7867491A (en) Compounds
AU639844B2 (en) Procaterol-containing plaster
AU8225391A (en) The use of inositolmonophosphate for the preparing of a medicament effective as a neuropeptide gamma-antagonist
GB9008123D0 (en) Pharmaceutical compounds
AU649061B2 (en) Single use syringe
AU8624791A (en) Compounds
AU6952291A (en) Pharmaceutically active oxazole compounds
AU1662092A (en) Use of a 1,3-oxathiolan derivative for the treatment of hepatitis b infection
GB9012252D0 (en) Pharmaceutical compounds
AU8852791A (en) Pyridil-pyrimidine derivatives as fungicidal compounds
AU8108391A (en) Use of pyrithione for the control of moss
AU643308B2 (en) 2-(9-fluorenonyl)-carbapenem
AU7709991A (en) Phenoxyphenylsulphonyl compounds
AU8432291A (en) Fungicidal sulfoneoxime esters
AU7866894A (en) The use of inositoltrisphosphate for the preparing of medicaments
AU632206B2 (en) Fungicidal azolylethane derivatives